|
|
|
2008³â05¿ù28ÀÏ 00½Ã00ºÐ |
|
|
|
|
±¹¸³¾Ï¼¾ÅÍ ¹ÚÁß¿ø ¹Ú»ç GSK Çмú³í¹®»ó ¼ö»ó
|
|
¹ÚÁß¿ø ±¹¸³¾Ï¼¾ÅÍ °£¾Ï¼¾ÅÍÀåÀÌ Áö³ 17ÀÏ ´ëÇÑ°£ÇÐȸ¿¡¼ ‘VEGF À¯ÀüÀÚ ´ÙÇü¼ºÀÌ °£¼¼Æ÷¾ÏÁ¾ ȯÀÚ »ýÁ¸¿¡ ¹ÌÄ¡´Â ¿µÇâ(Association between VEGF gene polymorphisms and survival in hepatocellular carcinoma patients)’À̶ó´Â ³í¹®À¸·Î GSK Çмú³í¹®»óÀ» ¼ö»óÇß´Ù.
|
|
|
|
|
|